287 related articles for article (PubMed ID: 15494722)
1. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
2. Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.
Chen J; Zhang H; Su F; Min J; Zhang J; Song E
Asian J Surg; 2002 Jan; 25(1):89-97. PubMed ID: 17585452
[TBL] [Abstract][Full Text] [Related]
3. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
5. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
7. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Kim KM; Lee K; Hong YS; Park HY
Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
[TBL] [Abstract][Full Text] [Related]
8. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
10. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells.
Zhou YW; Komada Y; Inaba H; Azuma E; Sakurai M
Cell Immunol; 1998 Jun; 186(2):103-10. PubMed ID: 9665752
[TBL] [Abstract][Full Text] [Related]
12. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
[TBL] [Abstract][Full Text] [Related]
13. The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis.
Houghton JA; Harwood FG; Gibson AA; Tillman DM
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2205-9. PubMed ID: 9815616
[TBL] [Abstract][Full Text] [Related]
14. Characterization of FAP-1 expression and function in thyroid follicular cells.
Myc A; Arscott PL; Bretz JD; Thompson NW; Baker JR
Endocrinology; 1999 Nov; 140(11):5431-4. PubMed ID: 10537175
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of cFLIP(L) in colonic adenocarcinoma.
Ryu BK; Lee MG; Chi SG; Kim YW; Park JH
J Pathol; 2001 May; 194(1):15-9. PubMed ID: 11329136
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.
Houston A; Waldron-Lynch FD; Bennett MW; Roche D; O'Sullivan GC; Shanahan F; O'Connell J
Int J Cancer; 2003 Nov; 107(2):209-14. PubMed ID: 12949796
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
[TBL] [Abstract][Full Text] [Related]
20. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.
Tillman DM; Harwood FG; Gibson AA; Houghton JA
Cell Death Differ; 1998 May; 5(5):450-7. PubMed ID: 10200495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
